Adient
ADNT
258 hedge funds and large institutions have $2.72B invested in Adient in 2022 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 74 increasing their positions, 79 reducing their positions, and 43 closing their positions.
414% more call options, than puts
Call options by funds: $31.3M | Put options by funds: $6.1M
0.61% less ownership
Funds ownership: 97.28% → 96.67% (-0.61%)
6% less repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 79
4% less funds holding
Funds holding: 270 → 258 (-12)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
21% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 43
26% less capital invested
Capital invested by funds: $3.68B → $2.72B (-$959M)
Top Buyers
| 1 |
GC
Greenvale Capital
London,
United Kingdom
|
+$62.2M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$22.8M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$13.4M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$10.9M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$9.99M |
Top Sellers
ADNT Hedge Fund Activity: Q2 2022 in Review
258 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Adient (ADNT) for Q2 2022, worth a combined $2.72B — down 26% from $3.68B a quarter earlier.
Sellers outnumbered buyers: 43 funds closed out of ADNT and 34 opened new positions — a net loss of 9 holders — while 79 trimmed existing stakes and 74 added.
The largest buyer was Greenvale Capital, adding an estimated $62.2M. The largest seller was Goldman Sachs, cutting an estimated $24.1M.
- 258 institutional investors held Adient (ADNT) as of Q2 2022, down from 270 in Q1 2022.
- Funds reported $2.72B of Adient stock for Q2 2022, down 26% quarter-over-quarter.
- 34 funds opened new Adient positions in Q2 2022 and 43 closed out, a net change of -9 holders.
- The largest Adient buyer in Q2 2022 was Greenvale Capital, an estimated $62.2M added.
- The largest Adient seller in Q2 2022 was Goldman Sachs, an estimated $24.1M sold.
Based on aggregated 13F filings for Q2 2022.